'Staircase' square-wave jerks in early Parkinson's disease

British Journal of Ophthalmology

Volumn 95, Issue 5, 2011, Pages 705-709

  Shaikh, Aasef G ^a   Xu Wilson, Minnan ^b   Grill, Stephen ^c   Zee, David S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Johns Hopkins University   (United States)

^c Parkinson's and Movement Disorders Center of Maryland   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EYE FIXATION; EYE MOVEMENT; EYE POSITION; GAZE; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SACCADIC EYE MOVEMENT; SHY DRAGER SYNDROME; SQUARE WAVE JERKS; SUBSTANTIA NIGRA PARS COMPACTA; SUBSTANTIA NIGRA PARS RETICULATA; SUPERIOR COLLICULUS; UNIFIED PARKINSON DISEASE RATING SCALE; VISUAL FIELD;

AGE OF ONSET; FEMALE; FIXATION, OCULAR; HUMANS; MALE; NEURAL PATHWAYS; OCULAR MOTILITY DISORDERS; PARKINSON DISEASE; REACTION TIME; SACCADES; SUBSTANTIA NIGRA;

EID: 79954990643     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.179630     Document Type: Article

References (27)

1. Optican LM, Rucker JC, Keller EL, et al. Mechanism of interrupted saccades in patients with late-onset TayeSachs disease. Prog Brain Res 2008;171:567-70.
2. Rucker JC, Shapiro BE, Han YH, et al. Neuro-ophthalmology of late-onset TayeSachs disease (LOTS). Neurology 2004;63:1918-26. (Pubitemid 39532391)
3. Hikosaka O, Wurtz RH. Modification of saccadic eye movements by GABA-related substances. II. Effects of muscimol in monkey substantia nigra pars reticulata. J Neurophysiol 1985;53:292-308. (Pubitemid 15174289)
4. Hikosaka O, Wurtz RH. Modification of saccadic eye movements by GABA-related substances. I. Effect of muscimol and bicuculline in monkey superior colliculus. J Neurophysiol 1985;53:266-91.
5. White OB, Saint-Cyr JA, Tomlinson RD, et al. Ocular motor deficits in Parkinson's disease. II. Control of the saccadic and smooth pursuit systems. Brain 1983;106:571-87.
6. Jones GM, DeJong JD. Dynamic characteristics of saccadic eye movements in Parkinson's disease. Exp Neurol 1971;31:17-31.
7. Blekher T, Weaver M, Rupp J, et al. Multiple step pattern as a biomarker in Parkinson disease. Parkinsonism Relat Disord 2009;15:506-10.
8. Crawford TJ, Henderson L, Kennard C. Abnormalities of nonvisually-guided eye movements in Parkinson's disease. Brain 1989;112:1573-86. (Pubitemid 20024222)
9. Hertel S, Sprenger A, Klein C, et al. Different saccadic abnormalities in PINK1 mutation carriers and in patients with non-genetic Parkinson's disease. J Neurol 2009;256:1192-4.
10. Leigh RJ, Zee DS. The neurology of eye movements. 4th edn. New York: Oxford University Press, 2006.
11. Serra A, Liao K, Martinez-Conde S, et al. Suppression of saccadic intrusions in hereditary ataxia by memantine. Neurology 2008;70:810-12.
12. Shaikh AG, Marti S, Tarnutzer AA, et al. Gaze fixation deficits and their implication in ataxia-telangiectasia. J Neurol Neurosurg Psychiatry 2009;80:858-64.
13. Rascol O, Sabatini U, Simonetta-Moreau M, et al. Square wave jerks in parkinsonian syndromes. J Neurol Neurosurg Psychiatry 1991;54:599-602.
14. Averbuch-Heller L, Stahl JS, Hlavin ML, et al. Square-wave jerks induced by pallidotomy in parkinsonian patients. Neurology 1999;52:185-8. (Pubitemid 29044424)
15. Robinson DA. A method of measuring eye movement using a scleral search coil in a magnetic fieldd. IEEE Trans Biomed Eng 1963;10:137-45.
16. Herishanu YO, Sharpe JA. Normal square wave jerks. Invest Ophthalmol Vis Sci 1981;20:268-72. (Pubitemid 11060847)
17. Abadi RV, Gowen E. Characteristics of saccadic intrusions. Vision Res 2004;44:2675-90. (Pubitemid 39092497)
18. Pakkenberg H, Brody H. The number of nerve cells in the substantia nigra in paralysis agitans. Acta Neuropathol 1965;5:320-4.
19. Gibb WR, Lees AJ. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry 1991;54:388-96.
20. Goetz CG, De Long MR, Penn RD, et al. Neurosurgical horizons in Parkinson's disease. Neurology 1993;43:1-7. (Pubitemid 23035348)
21. Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990;249:1436-8.
22. Plenz D, Kital ST. A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus. Nature 1999;400:677-82.
23. Bergman H, Wichmann T, Karmon B, et al. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 1994;72:507-20. (Pubitemid 24273560)
24. Samuel M, Ceballos-Baumann AO, Turjanski N, et al. Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements an H2(15)O PET study. Brain 1997;120:1301-13.
25. Sommer MA, Wurtz RH. Influence of the thalamus on spatial visual processing in frontal cortex. Nature 2006;444:374-7. (Pubitemid 44764113)
26. Sommer MA, Wurtz RH. What the brain stem tells the frontal cortex. I. Oculomotor signals sent from superior colliculus to frontal eye field via mediodorsal thalamus. J Neurophysiol 2004;91:1381-402.
27. Berman RA, Joiner WM, Cavanaugh J, et al. Modulation of presaccadic activity in the frontal eye field by the superior colliculus. J Neurophysiol 2009;101:2934-42.